Pancreatic Cancer Research

ResearcherSir Run Run Shaw HospitalNo recent work listed

Weihua Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3674-0476; OpenAlex author ID A5041629791. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 3 papers

Papers 3

  1. The distinct role of CD73 in the progression of pancreatic cancer. Co-author DOI 10.1007/s00109-018-01742-0↗
  2. Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.7150/jca.31191↗
  3. The up-regulation of Axl is associated with a poor prognosis and promotes proliferation in pancreatic ductal adenocarcinoma. Co-author PMID 31933980↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Liangjing Zhou · 2 shared papers, 2019 · strength 0.20
  2. Guoping Ding · 2 shared papers, 2019 · strength 0.20
  3. Mingjie Zhang · 2 shared papers, 2019 · strength 0.20
  4. Shengnan Jia · 2 shared papers, 2019 · strength 0.20
  5. Zhengrong Wu · 2 shared papers, 2019 · strength 0.20
  6. Liping Cao · 2 shared papers, 2019 · strength 0.20
  7. Yong Wang · 1 shared paper, 2019 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.